Company Filing History:
Years Active: 2025
Title: The Innovations of Sebastian Fenn
Introduction
Sebastian Fenn is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work has implications for therapeutic applications, showcasing the potential of innovative solutions in medicine.
Latest Patents
Sebastian Fenn holds a patent for bispecific anti-human A-beta/anti-human transferrin receptor antibodies. This patent outlines methods of using these antibodies, which are designed to target specific proteins associated with various diseases. His innovative approach highlights the importance of targeted therapies in modern medicine. He has 1 patent to his name.
Career Highlights
Throughout his career, Sebastian Fenn has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG, where he contributed to groundbreaking research and development projects. His experience in these organizations has equipped him with valuable insights into the complexities of drug development.
Collaborations
Sebastian has collaborated with esteemed colleagues such as Harald Duerr and Ulrich Goepfert. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Sebastian Fenn's contributions to the field of biotechnology through his patent and collaborations demonstrate his commitment to advancing medical science. His work exemplifies the impact of innovative thinking in addressing complex health challenges.